LIPOSOMAL MELATONIN 60MG

While melatonin is widely known for regulating sleep, high-dose therapy—often exceeding 100 mg—is being studied for its potential "oncostatic" (cancer-inhibiting) properties. Using a liposomal delivery system is a specific strategy to bypass the limitations of standard oral supplements. ​Here is an explanation of the mechanisms and why the liposomal format is used in this context. ​1. The Liposomal Advantage ​Standard melatonin capsules have low bioavailability (often only 10–15%) because they are heavily processed by the liver before entering the bloodstream. ​Bioavailability: Liposomal formulations encapsulate melatonin in tiny fat bubbles (lipid vesicles) that protect it from stomach acid and bypass the liver's first-pass metabolism. ​Intracellular Delivery: Because liposomes mimic the body’s cell membranes, they can fuse directly with cells, delivering the melatonin directly into the cytoplasm and mitochondria where its antioxidant effects are most potent. ​2. Core Anti-Cancer Mechanisms ​At high doses, melatonin moves beyond sleep regulation and acts as a powerful bioactive molecule: ​Apoptosis Induction: Melatonin can trigger "programmed cell death" in cancer cells by increasing oxidative stress specifically within the tumor, while simultaneously protecting healthy cells. ​The Warburg Effect Reversal: Cancer cells often switch to a less efficient metabolism to fuel rapid growth (the Warburg Effect). High-dose melatonin can suppress this metabolic shift, essentially "starving" the tumor's energy production. ​Anti-Angiogenesis: It has been shown to inhibit the formation of new blood vessels that tumors need to grow and spread (metastasis). ​Immune Modulation: It can enhance the activity of Natural Killer (NK) cells and T-lymphocytes, which are the body's primary defense against malignant cells. ​3. Synergistic Effects with Standard Care ​Clinical research often focuses on melatonin as an adjuvant (add-on) therapy: ​Radiosensitization: It may make cancer cells more sensitive to radiation while protecting surrounding healthy tissue from damage. ​Reduced Toxicity: Studies have suggested that high-dose melatonin can reduce the side effects of chemotherapy, such as fatigue, nausea, and bone marrow suppression. ​4. Safety and Considerations ​A dose of 120 mg is significantly higher than the standard 1–5 mg used for sleep. ​Non-Toxic Profile: Most studies indicate that even very high doses of melatonin are remarkably non-toxic to healthy cells. ​1. Prostate Cancer (PCa) ​Research identifies prostate cancer as highly sensitive to melatonin because it modulates both metabolic and hormonal pathways. ​Androgen Receptor Modulation: Melatonin can physically interfere with androgen receptors, essentially helping to "block" the signals that drive prostate cancer growth. ​Survival Rates: A significant clinical study (re-evaluated in late 2024) observed that in patients with poor-prognosis prostate cancer, those taking melatonin alongside hormone and radiation therapy had a median overall survival of 153.5 months, compared to 64 months in the control group. ​Metabolic Starvation: It acts as a competitive inhibitor of GLUT1, a transporter that cancer cells use to gorge on glucose. By blocking this, melatonin helps starve the tumor cells of their primary fuel.